YCBD cbdMD Inc

  1. Stocks
  2. Healthcare
  3. NYSEAMERICAN: YCBD

Price (delayed)

$0.4574

Market cap

$5.13M

P/E Ratio

1.91

Dividend/share

N/A

EPS

$0.24

Enterprise value

$5.22M

?
Relative Growth: Rel. Growth: 44
Relative Strength: Rel. Strength: 6
Relative Valuation: Rel. Valuation: 94
Relative Profitability: Rel. Profitability: 19

cbdMD, Inc. (NYSE American: YCBD) is a Charlotte, North Carolina-based hemp-derived wellness company committed to safe, high-quality, science-backed products. Its family of brands includes cbdMD, cbdMD Science, Bluebird Botanicals, Paw ...

Highlights
The EPS has soared by 114% year-on-year and by 71% since the previous quarter
The revenue has increased by 10% YoY and by 4.7% from the previous quarter
The quick ratio has soared by 121% YoY but it has decreased by 11% from the previous quarter
YCBD's equity is up by 34% year-on-year but it is down by 12% since the previous quarter
The company's debt has surged by 130% YoY
The net income has shrunk by 91% YoY and by 9% QoQ
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: https://www.cbdmd.com

Key stats

What are the main financial stats of YCBD

YCBD stock price

How has the cbdMD stock price performed over time
Intraday
-8.52%
1 week
-1.85%
1 month
-10.12%
1 year
-30.86%
YTD
-66.12%
QTD
-32.04%

Financial performance

How have cbdMD's revenue and profit performed over time
Revenue
$20.93M
Gross profit
$12.07M
Operating income
-$2.9M
Net income
-$2.89M
Gross margin
57.7%
Net margin
-13.8%
The net income has shrunk by 91% YoY and by 9% QoQ
The company's net margin has shrunk by 73% YoY and by 3.8% QoQ
cbdMD's operating income has plunged by 62% YoY and by 8% from the previous quarter
YCBD's operating margin is down by 48% year-on-year and by 3.7% since the previous quarter

Price vs fundamentals

How does YCBD's price correlate with its fundamentals

Growth

What is cbdMD's growth rate over time

Valuation

What is cbdMD stock price valuation
P/E
1.91
P/B
0.58
P/S
0.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.25
The EPS has soared by 114% year-on-year and by 71% since the previous quarter
The stock's P/B is 47% below its last 4 quarters average of 1.2 and 29% below its 5-year quarterly average of 0.9
YCBD's equity is up by 34% year-on-year but it is down by 12% since the previous quarter
YCBD's P/S is 50% below its 5-year quarterly average of 0.5 and 38% below its last 4 quarters average of 0.4
The revenue has increased by 10% YoY and by 4.7% from the previous quarter

Efficiency

How efficient is cbdMD business performance
The company's return on equity has surged by 80% YoY and by 7% QoQ
The ROS has dropped by 73% year-on-year and by 3.8% since the previous quarter
The ROA has grown by 43% YoY and by 8% from the previous quarter
YCBD's ROIC is up by 13% QoQ

Dividends

What is YCBD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for YCBD.

Financial health

How did cbdMD financials performed over time
The total assets is 166% more than the total liabilities
The quick ratio has soared by 121% YoY but it has decreased by 11% from the previous quarter
YCBD's total liabilities has soared by 66% since the previous quarter and by 30% year-on-year
The company's debt is 73% lower than its equity
The company's debt has surged by 130% YoY
The debt to equity has soared by 69% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.